Ben Sklaroff is the founder of Genesis Therapeutics. Genesis Therapeutics has raised $280M in total funding. Latest round: Series B.
Ben Sklaroff is the Co-Founder and Chief Technology Officer (CTO) of Genesis Therapeutics, an AI-driven drug discovery company that originated from Stanford University research. He has been in this role since January 2019, guiding the company's technical advancements in AI for medicine.
Full founder directory · Investor directory · Company funding database · Fundraising library